The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Christopher Nishan Garabedian since year 2005.
The trader's CIK number is 1492604.
At the time of this reporting, Christopher Nishan Garabedian is the President and CEO of Avi Biopharma Inc .
(stock ticker symbol AVII).
See this page for all insider trading activities at Avi Biopharma Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-02-27||SRPT||Avi Biopharma Inc||Buy||800||11.82||9,452|
|2011-12-15||AVII||Avi Biopharma Inc||Buy||300,000||.58||173,700|
|2011-04-06||AVII||Avi Biopharma Inc||Buy||130,000||1.50||195,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Christopher Nishan Garabedian (President and CEO of Avi Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.